Ledger.Open graph →
SEC Form D · filed January 18, 2022

SV Biotech Crossover Opportunities Fund LP

Offering
$350.0M
Sold
$135.2M
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
LONDON, United Kingdom
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Kate Bingham · London, United KingdomExecSv Health Managers Llp · London, United KingdomPromoterSv Bco I Gp Llp · London, United KingdomExec · DirectorNicola Trbovic · London, United KingdomExecBruce H. Cox · Palm Beach, FLExecSv Bco I Gp Llp · London, United KingdomExec · DirectorEdward T. Van Brunt · Phoenix, AZExecCarlyon Knight-Evans · Mid-Levels West, Hong KongExecNicola Trbovic · London, United KingdomExecSv Health Managers Llp · London, United KingdomPromoterHouman Ashrafian · London, United KingdomExecDaniel P. Stauder · Willowbrook, ILExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗